Company Overview
Calyxt (Nasdaq: CLXT) is a plant-based synthetic biotechnology company. The Company leverages its proprietary PlantSpring™ technology platform to engineer innovative materials and products for its customers to help them meet their sustainability goals. Calyxt’s diversified offerings are primarily delivered through its proprietary BioFactory™ production system.
Latest Financial Results
FY 2022
Fiscal Year Ended December 31, 2022
Latest Annual Filing
For Fiscal Year Ending Dec 31, 2022
Report Links
Email Alerts
Sign up today and receive company updates straight to your inbox.
Investor Contact Information
Company
Calyxt, Inc.
2800 Mount Ridge Road
Roseville, MN 55113
Investor Relations
Argot Partners
Kimberly Minarovich
Cameron Willis
T: 212-600-1902
investors@calyxt.com
Transfer Agent
Broadridge Corporate Issuer Solutions, Inc.
1155 Long Island Avenue
Edgewood, NY 11717
T: 1-877-830-4932
https://www.broadridge-ir.com/resources/transfer-agent/default.aspx
